Trial · NCT00570661
Adverse events26
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 26
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injury | Injury, poisoning and procedural complications | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Electrocardiogram QT prolonged | Investigations | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Atelectasis | Respiratory, thoracic and mediastinal disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | IT2357 - Safety Population | 3 | 17 | 3 |
| other | Fatigue | General disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Pyrexia | General disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Depression | Psychiatric disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Enteritis | Gastrointestinal disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Nausea | Gastrointestinal disorders | IT2357 - Safety Population | 1 | 17 | 6 |
| other | Vomiting | Gastrointestinal disorders | IT2357 - Safety Population | 1 | 17 | 3 |
| other | Haematuria | Renal and urinary disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Nephrolithiasis | Renal and urinary disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Dermatitis contact | Skin and subcutaneous tissue disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Rash | Skin and subcutaneous tissue disorders | IT2357 - Safety Population | 2 | 17 | 3 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | IT2357 - Safety Population | 1 | 17 | 1 |
| other | Arthritis | Musculoskeletal and connective tissue disorders | IT2357 - Safety Population | 3 | 17 | 3 |
| other | Joint swelling | Musculoskeletal and connective tissue disorders | IT2357 - Safety Population | 1 | 17 | 3 |
| other | Influenza | Infections and infestations | IT2357 - Safety Population | 2 | 17 | 2 |
| other | Nasopharyngitis | Infections and infestations | IT2357 - Safety Population | 1 | 17 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00570661/events